The EXPAND II Pivotal Trial is a global, randomized clinical study evaluating the self-expanding, supra-annular Evolut™ TAVR platform in patients with moderate, symptomatic aortic stenosis, outside of current indications for TAVR.
The EXPAND II Pivotal Trial is a global, randomized clinical study evaluating the self-expanding, supra-annular Evolut™ TAVR platform in patients with moderate, symptomatic aortic stenosis, outside of current indications for TAVR.
The EXPAND II Pivotal Trial is a...